Provided by Tiger Trade Technology Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.79
+0.05002.87%
Volume:24.69K
Turnover:43.81K
Market Cap:4.72M
PE:-0.15
High:1.80
Open:1.79
Low:1.75
Close:1.74
52wk High:17.68
52wk Low:1.29
Shares:2.64M
Float Shares:2.49M
Volume Ratio:0.88
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.7300
EPS(LYR):-74.1816
ROE:-200.92%
ROA:-87.17%
PB:-0.77
PE(LYR):-0.02

Loading ...

60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Yesterday

60 Degrees Pharma CEO touts tafenoquine expansion push into babesiosis in Bloomberg TV interview

Reuters
·
Apr 02

Analysts Offer Insights on Healthcare Companies: Danaher (DHR), 60 Degrees Pharmaceuticals, Inc. (SXTP) and BridgeBio Pharma (BBIO)

TIPRANKS
·
Mar 31

60 Degrees Q4 EPS $(1.47) Misses $(1.12) Estimate, Sales $303.385K Miss $400.000K Estimate

Benzinga
·
Mar 31

Press Release: 60 Degrees Pharmaceuticals Announces 2025 Annual Results

Dow Jones
·
Mar 31

60 Degrees Pharma FY25 operating loss narrows 16.24% to $8.4 million

Reuters
·
Mar 31

60 Degrees Updates Affiliate Share Ownership Disclosure Error

TIPRANKS
·
Mar 21

60 Degrees Pharmaceuticals corrects affiliate beneficial ownership to 23,367 shares

Reuters
·
Mar 21

BRIEF-60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract

Reuters
·
Mar 18

60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering

TIPRANKS
·
Mar 14

What's Going On With 60 Degrees Pharmaceuticals On Friday?

Benzinga_recent_news
·
Mar 13

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM

Reuters
·
Mar 12

60 Degrees Pharmaceuticals reports 100% babesiosis cure rate in tafenoquine expanded access trial

Reuters
·
Mar 11

60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial

THOMSON REUTERS
·
Mar 11

BRIEF-60 Degrees Pharmaceuticals Company Regained Compliance With Nasdaq Minimum Bid Price

Reuters
·
Feb 12

60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status

TIPRANKS
·
Feb 12

60 Degrees expands access to Arakoda with GoodRx partnership

TIPRANKS
·
Feb 02

60 Degrees Pharmaceuticals Partners with GoodRx to Offer Savings on Malaria Drug ARAKODA

Reuters
·
Feb 02

60 Degrees Pharmaceuticals Expands Access to Arakoda® With GoodRx Partnership

THOMSON REUTERS
·
Feb 02

60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use

GlobeNewswire
·
Jan 28